Melina Elpi Marmarelis, MD

Benjamin A. Bleiberg, Dylan G. Scholes, Lauren Reed-Guy, Devaki Dravid, Lova L. Sun, Aditi P. Singh, Roger B. Cohen, Corey J. Langer, Melina E. Marmarelis, Charu Aggarwal The incremental value of liquid biopsy in the initial evaluation of patients with metastatic non-small cell lung cancer undergoing tissue-based molecular testing , The Journal of Liquid Biopsy, 12: 2026

Sam O. Kleeman; Yosef Riazat-Kesh; Richard Carvajal; Melina E. Marmarelis; Dirk Schadendorf; Elad Sharon; Megan Othus; Caroline Robert; Ferdinandos Skoulidis; Benjamin Izar; Robert G. Maki; Tobias Janowitz. Cancer chemo-immunotherapy: time will tell , Cancer Immunology Research: 2026

Benjamin A. Bleiberg, Lauren Reed-Guy, Roger B. Cohen, Charu Aggarwal, Corey J. Langer, Aditi P. Singh, Melina E. Marmarelis Carboplatin plus Pemetrexed versus Pemetrexed alone in Advanced Thymoma and Thymic Carcinoma: A Retrospective Cohort Study , Frontiers: 2026

Cole Friedes, Michelle Iocolano, Nikhil Yegya-Raman, John C Kucharczuk, Taine T V Pechet, Roger B Cohen, Charu Aggarwal, Melina E Marmarelis, William P Levin, Keith A Cengel, Christine A Ciunci, Christopher D'Avella, Aditi P Singh, Christiana W Davis, Corey J Langer, Jeffrey Bradley, Steven J Feigenberg Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant Chemoimmunotherapy , American Journal of Clinical Oncology: 2026

Teja Voruganti, Christiana Davis, Melina E. Marmarelis, Charu Aggarwal Illusion of Comprehensive Testing in Non–Small Cell Lung Cancer: Why Coverage, Sensitivity, and Reporting Matter , JCO Oncology Practice: 2026

Melina E. Marmarelis, Adrienne M. Gilligan, Tomoko Sugihara, Shen Zheng, Tyler Marquart, Samuel Whipple, Naleen Raj Bhandari, Charu Aggarwal Evaluation of Guideline-Recommended Care in First-Line Treatment for Advanced/Metastatic Non-Small Cell Lung Cancer Patients who underwent Next-Generation Sequencing Testing: Results from a Real-World Study , Cancer Treatment and Research Communications: 2026

Benjamin T. Cooper, Jeffrey D. Bradley, Sushma Patel, Michael A. Pritchett, Steven J. Feigenberg, Kevin C. Ma, Isaac Laniado, Melina E. Marmarelis, Matthew Scarlotta, Joshua K. Sabari, Yi-Wen Ma, Yina Kuang, Kiran Devisetty, Balaji Laxmanan, David M. DiBardino Novel Intratumoral Radioenhancer (JNJ -1900) with Chemoradiation and Consolidative Immunotherapy for Stage III Unresectable Non -Small Cell Lung Cancer (NSCLC): Early Outcomes from the Phase II CONVERGE Study , ELCC 2026 Poster: 2026

Adam Barsouk, Alec Heidlauf, Keshav Goel, Lynn Rushkin, Anna Anran Huang, Omar Elghawy, Connie Yu, Lucy Wang, David Yang, Martin Kurian, Lauren Reed-Guy, Lova Sun, Aditi Singh, Charu Aggarwal, Roger B. Cohen, Corey Langer, Melina E. Marmarelis Osimertinib Dose-Reduction and Survival in First-Line EGFR-Mutated mNSCLC , Lung Cancer, 213: 2026,108936

Michael Offin...Melina E. Marmarelis eVOLVE-02 SS5 Meso TiP Abstract entitled: Volrustomig, a novel bispecific PD-1/CTLA-4 monoclonal antibody, as single-agent first-line therapy for unresectable pleural mesothelioma (PM): Substudy 5 of the eVOLVE-02 phase 2 study. , ELCC March 2026: 2026

Pascale Tomasini, MD, MSc, Yongsheng Wang, MD, Yongsheng Li, MD, PhD, Enriqueta Felip, MD, PhD, Lin Wu, MD, Jiuwei Cui, MD, PhD, Benjamin Besse, MD, PhD, Alexander I. Spira, MD, PhD, Joel W. Neal, MD, Ph, Koichi Goto, MD, PhD, Christina S. Baik, MD, MPH, Melina E. Marmarelis, MD, Eiki Ichihara, MD, PhD, Yiping Zhang, MD, Jong-Seok Lee, MD, PhD, Se-Hoon Lee, MD, PhD, James Chih-Hsin Yang, MD, PhD, Sebastian Michels, MD, Zacharias Anastasiou, MS, Joshua C. Curtin, PhD, Xuesong Lyu, PhD, Janine Mahoney, BSN, RN, Levon Demirdjian, PhD, Craig S. Meyer, MS, PhD, MPH, Youyi Zhang, PhD, Isabelle Leconte, PhD, Patricia Lorenzini, MS, Roland E. Knoblauch, MD, PhD, Leonardo Trani, MD, Mahadi Baig, MD, Joshua M. Bauml, MD, Byoung Chul Cho, MD, PhD Amivantamab Plus Lazertinib in Atypical EGFR-Mutated Advanced Non–Small Cell Lung Cancer: Results From CHRYSALIS-2 , Journal of Clinical Oncology, 44(1): 2026,54-65.